Latest news with #Organigram
National Post
08-07-2025
- Business
- National Post
Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio
Article content TORONTO — Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the 'Company' or 'Organigram'), Canada's #1 cannabis company by market share, announced today that its recently acquired beverage business, Collective Project, has launched an e-commerce platform in the U.S. marking a key milestone in the Company's strategic expansion into the rapidly evolving U.S. hemp-derived THC beverage market. The launch also includes a bold new portfolio of hemp-derived THC beverages designed to meet diverse consumer preferences. Article content In response to consumer demand for accessible, high-quality THC beverages, the Company's e-commerce platform at expands U.S. consumer access to these products across 25 states. The launch represents a milestone in Organigram's multi-phase U.S. expansion strategy, enhancing the Company's presence in a category experiencing growth. The hemp-derived THC beverage market in the U.S. has already surpassed $1 billion in retail sales and is projected to reach $4 billion by 2028 1. Article content Article content The platform launches with an expanded and diverse line of products for every occasion, including Sparkling Juices and Sparkling Lemonades. Available in multiple pack sizes and THC dosages, the beverages are designed to cater to a range of preferences and experience levels, from curious newcomers to seasoned connoisseurs. The second phase of the launch will include Fetch, a new line of bold hemp-derived THC sodas set to launch later this summer, with details to be announced. Article content 'We remain bullish on the hemp-derived THC opportunity and are thrilled to expand both our portfolio and our access to consumers across the U.S.,' said Megan McCrae, SVP, Corporate Strategy & International Growth, Organigram Global. 'The early momentum we've seen including listings with major retail chains like Total Wine & More and Top Ten Liquors reinforces our belief in the category's potential.' Article content Organigram's entry into the high-growth hemp-derived THC beverage market in the U.S. builds on its strong track record in Canada, where the Company holds the #1 market share position driven by innovation, popular consumer brands, and operational excellence. This next phase of expansion positions Organigram to unlock broader sales channels and accelerate topline growth. With Collective Project already well established in Canada's retail cannabis space, the U.S. e-commerce rollout represents a new revenue stream and a critical step toward international growth. Article content In addition to direct online shipping, Collective Project beverages are available at select retail partners in many states. Article content *Collective Project is now shipping to Arkansas, Delaware, Florida, Georgia, Illinois, Indiana, Kansas, Maine, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Wisconsin and Wyoming. Article content About Collective Project Article content Collective Project is a Canadian cannabis and U.S. hemp beverage brand. We believe that a creative world is a better world and we're on a mission to bring inspiration, collaboration and creativity into everyday life. Our unique THC beverages are made with real fruit juice, clean ingredients, and balanced dosing, offering a bold, flavourful way to enjoy cannabis and hemp-derived products. More than a drink, each can is a collaboration between flavour creators and visual artists, turning everyday moments into something expressive, social, and a little more inspired. Article content About Organigram Article content Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. Through its acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverage markets. Article content Organigram is focused on producing high-quality cannabis for adult consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada). Article content Forward-Looking Information Article content This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include consumer demand and preferences and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Examples of forward-looking statements in this news release include, among others, the opportunities for cannabis beverages in the U.S. and Organigram's ability to establish a U.S. market position over time for hemp-derived THC products in beverages, the Fetch brand launch and timing thereof and changing regulatory requirements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release is made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. Article content Article content Article content Article content Article content Contacts Article content Article content Article content
Yahoo
08-07-2025
- Business
- Yahoo
Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio
TORONTO, July 08, 2025--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, announced today that its recently acquired beverage business, Collective Project, has launched an e-commerce platform in the U.S. marking a key milestone in the Company's strategic expansion into the rapidly evolving U.S. hemp-derived THC beverage market. The launch also includes a bold new portfolio of hemp-derived THC beverages designed to meet diverse consumer preferences. In response to consumer demand for accessible, high-quality THC beverages, the Company's e-commerce platform at expands U.S. consumer access to these products across 25 states. The launch represents a milestone in Organigram's multi-phase U.S. expansion strategy, enhancing the Company's presence in a category experiencing growth. The hemp-derived THC beverage market in the U.S. has already surpassed $1 billion in retail sales and is projected to reach $4 billion by 20281. The platform launches with an expanded and diverse line of products for every occasion, including Sparkling Juices and Sparkling Lemonades. Available in multiple pack sizes and THC dosages, the beverages are designed to cater to a range of preferences and experience levels, from curious newcomers to seasoned connoisseurs. The second phase of the launch will include Fetch, a new line of bold hemp-derived THC sodas set to launch later this summer, with details to be announced. "We remain bullish on the hemp-derived THC opportunity and are thrilled to expand both our portfolio and our access to consumers across the U.S.," said Megan McCrae, SVP, Corporate Strategy & International Growth, Organigram Global. "The early momentum we've seen including listings with major retail chains like Total Wine & More and Top Ten Liquors reinforces our belief in the category's potential." Organigram's entry into the high-growth hemp-derived THC beverage market in the U.S. builds on its strong track record in Canada, where the Company holds the #1 market share position driven by innovation, popular consumer brands, and operational excellence. This next phase of expansion positions Organigram to unlock broader sales channels and accelerate topline growth. With Collective Project already well established in Canada's retail cannabis space, the U.S. e-commerce rollout represents a new revenue stream and a critical step toward international growth. In addition to direct online shipping, Collective Project beverages are available at select retail partners in many states. *Collective Project is now shipping to Arkansas, Delaware, Florida, Georgia, Illinois, Indiana, Kansas, Maine, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Wisconsin and Wyoming. About Collective ProjectCollective Project is a Canadian cannabis and U.S. hemp beverage brand. We believe that a creative world is a better world and we're on a mission to bring inspiration, collaboration and creativity into everyday life. Our unique THC beverages are made with real fruit juice, clean ingredients, and balanced dosing, offering a bold, flavourful way to enjoy cannabis and hemp-derived products. More than a drink, each can is a collaboration between flavour creators and visual artists, turning everyday moments into something expressive, social, and a little more inspired. About OrganigramOrganigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. Through its acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverage markets. Organigram is focused on producing high-quality cannabis for adult consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada). Forward-Looking Information This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "estimates", "intends", "anticipates", "believes" or variations of such words and phrases or state that certain actions, events, or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include consumer demand and preferences and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Examples of forward-looking statements in this news release include, among others, the opportunities for cannabis beverages in the U.S. and Organigram's ability to establish a U.S. market position over time for hemp-derived THC products in beverages, the Fetch brand launch and timing thereof and changing regulatory requirements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release is made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. 1 "Fizz with a Buzz: The Rise of Cannabis Drinks in the US", Euromonitor International, June 11, 2024, View source version on Contacts For Media enquiries: Mark McKay – Director of Max Schwartz – Director of Investor Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
08-07-2025
- Business
- Business Wire
Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the 'Company' or 'Organigram'), Canada's #1 cannabis company by market share, announced today that its recently acquired beverage business, Collective Project, has launched an e-commerce platform in the U.S. marking a key milestone in the Company's strategic expansion into the rapidly evolving U.S. hemp-derived THC beverage market. The launch also includes a bold new portfolio of hemp-derived THC beverages designed to meet diverse consumer preferences. In response to consumer demand for accessible, high-quality THC beverages, the Company's e-commerce platform at expands U.S. consumer access to these products across 25 states. The launch represents a milestone in Organigram's multi-phase U.S. expansion strategy, enhancing the Company's presence in a category experiencing growth. The hemp-derived THC beverage market in the U.S. has already surpassed $1 billion in retail sales and is projected to reach $4 billion by 2028 1. The platform launches with an expanded and diverse line of products for every occasion, including Sparkling Juices and Sparkling Lemonades. Available in multiple pack sizes and THC dosages, the beverages are designed to cater to a range of preferences and experience levels, from curious newcomers to seasoned connoisseurs. The second phase of the launch will include Fetch, a new line of bold hemp-derived THC sodas set to launch later this summer, with details to be announced. 'We remain bullish on the hemp-derived THC opportunity and are thrilled to expand both our portfolio and our access to consumers across the U.S.,' said Megan McCrae, SVP, Corporate Strategy & International Growth, Organigram Global. 'The early momentum we've seen including listings with major retail chains like Total Wine & More and Top Ten Liquors reinforces our belief in the category's potential.' Organigram's entry into the high-growth hemp-derived THC beverage market in the U.S. builds on its strong track record in Canada, where the Company holds the #1 market share position driven by innovation, popular consumer brands, and operational excellence. This next phase of expansion positions Organigram to unlock broader sales channels and accelerate topline growth. With Collective Project already well established in Canada's retail cannabis space, the U.S. e-commerce rollout represents a new revenue stream and a critical step toward international growth. In addition to direct online shipping, Collective Project beverages are available at select retail partners in many states. *Collective Project is now shipping to Arkansas, Delaware, Florida, Georgia, Illinois, Indiana, Kansas, Maine, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Wisconsin and Wyoming. About Collective Project Collective Project is a Canadian cannabis and U.S. hemp beverage brand. We believe that a creative world is a better world and we're on a mission to bring inspiration, collaboration and creativity into everyday life. Our unique THC beverages are made with real fruit juice, clean ingredients, and balanced dosing, offering a bold, flavourful way to enjoy cannabis and hemp-derived products. More than a drink, each can is a collaboration between flavour creators and visual artists, turning everyday moments into something expressive, social, and a little more inspired. About Organigram Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. Through its acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverage markets. Organigram is focused on producing high-quality cannabis for adult consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada). Forward-Looking Information This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include consumer demand and preferences and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Examples of forward-looking statements in this news release include, among others, the opportunities for cannabis beverages in the U.S. and Organigram's ability to establish a U.S. market position over time for hemp-derived THC products in beverages, the Fetch brand launch and timing thereof and changing regulatory requirements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release is made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. 1
National Post
27-05-2025
- Business
- National Post
Organigram Global Announces CEO Succession Plan
Article content Article content TORONTO — Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), ('the Company' or 'Organigram'), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the 'Board') to advance Organigram's strategic objectives, including international expansion, and to ensure an effective transition. Article content Since joining Organigram as CEO in September 2021, Ms. Goldenberg successfully led the organization's growth and transformation from a cannabis company with $80M in net revenue to becoming the market share leader in Canada with over $250M in net revenue. Under her leadership, the Company completed an expansion of its facility in Moncton, New Brunswick, doubling cultivation capacity, as well as three strategic acquisitions that led to the Company's #1 share positions in vapes, hash and pre-rolls in Canada. In addition, Ms. Goldenberg oversaw Organigram's international expansion with export sales into Germany, UK and Australia. The latest acquisition of Collective Project, announced on April 1, 2025, signaled the first revenue recognized by Organigram from the U.S. market. Article content This announcement follows the Company's second quarter fiscal year 2025 results, which were issued on May 12, 2025, and highlight the progress that has been made in enhancing Organigram's financial performance. This includes realizing a 74% increase in net revenue year-over-year and delivering improvement across key financial metrics. Article content 'After five incredible years in the cannabis industry, serving as CEO of Supreme Cannabis Company and Organigram Global, I have decided it is time to move on to my next chapter,' said Ms. Goldenberg. 'Reflecting on my journey, I am extremely proud of what has been accomplished in this nascent industry. The challenges we faced and the successes we achieved underscore the immense potential that still lies ahead for the cannabis industry.' Article content 'On behalf of the Board, I express our gratitude to Beena for her exceptional leadership and commitment to Organigram. Beena has been instrumental in positioning Organigram as a market leader in Canada and poised for global expansion,' said Peter Amirault, Chairman of the Board, Organigram. 'She has created an excellent base for both domestic and international growth for Organigram. And therefore, the Company is well positioned to take advantage of this significant opportunity. The Board remains confident in the Company's strategic direction as well as its leadership team, and we are committed to appointing a new CEO who will continue to drive our vision forward, ensuring that the Company remains at the forefront of cannabis innovation and growth.' Article content The Board is in the process of initiating a comprehensive CEO selection process focused on identifying a candidate with the right mix of skills and experience to lead the Company in its next chapter of growth. Article content 'It has been an honour to lead Organigram Global through this critical chapter in our evolution, and I am grateful to have had the privilege of working with so many talented and passionate people who have played a significant role in our collective growth and achievements,' said Ms. Goldenberg. 'Over the next four months I will remain focused on driving Organigram growth and profitability while supporting the smooth onboarding of a new CEO to lead the Company forward in its next phase of growth.' Article content Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor of cannabis and manufacturer of cannabis-derived goods in Canada. Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets. Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, Collective Project, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Article content This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include consumer demand and preferences, future prospects and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Article content Examples of forward-looking statements in this news release include, among others, statements regarding the Board's intended CEO selection process, Organigram's strategic direction and Ms. Goldenberg's planned focus until her retirement date. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Article content Article content Article content Article content Article content Article content
Business Wire
27-05-2025
- Business
- Business Wire
Organigram Global Announces CEO Succession Plan
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), ('the Company' or 'Organigram'), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the 'Board') to advance Organigram's strategic objectives, including international expansion, and to ensure an effective transition. Since joining Organigram as CEO in September 2021, Ms. Goldenberg successfully led the organization's growth and transformation from a cannabis company with $80M in net revenue to becoming the market share leader in Canada with over $250M in net revenue. Under her leadership, the Company completed an expansion of its facility in Moncton, New Brunswick, doubling cultivation capacity, as well as three strategic acquisitions that led to the Company's #1 share positions in vapes, hash and pre-rolls in Canada. In addition, Ms. Goldenberg oversaw Organigram's international expansion with export sales into Germany, UK and Australia. The latest acquisition of Collective Project, announced on April 1, 2025, signaled the first revenue recognized by Organigram from the U.S. market. This announcement follows the Company's second quarter fiscal year 2025 results, which were issued on May 12, 2025, and highlight the progress that has been made in enhancing Organigram's financial performance. This includes realizing a 74% increase in net revenue year-over-year and delivering improvement across key financial metrics. 'After five incredible years in the cannabis industry, serving as CEO of Supreme Cannabis Company and Organigram Global, I have decided it is time to move on to my next chapter,' said Ms. Goldenberg. 'Reflecting on my journey, I am extremely proud of what has been accomplished in this nascent industry. The challenges we faced and the successes we achieved underscore the immense potential that still lies ahead for the cannabis industry.' 'On behalf of the Board, I express our gratitude to Beena for her exceptional leadership and commitment to Organigram. Beena has been instrumental in positioning Organigram as a market leader in Canada and poised for global expansion,' said Peter Amirault, Chairman of the Board, Organigram. 'She has created an excellent base for both domestic and international growth for Organigram. And therefore, the Company is well positioned to take advantage of this significant opportunity. The Board remains confident in the Company's strategic direction as well as its leadership team, and we are committed to appointing a new CEO who will continue to drive our vision forward, ensuring that the Company remains at the forefront of cannabis innovation and growth.' The Board is in the process of initiating a comprehensive CEO selection process focused on identifying a candidate with the right mix of skills and experience to lead the Company in its next chapter of growth. 'It has been an honour to lead Organigram Global through this critical chapter in our evolution, and I am grateful to have had the privilege of working with so many talented and passionate people who have played a significant role in our collective growth and achievements,' said Ms. Goldenberg. 'Over the next four months I will remain focused on driving Organigram growth and profitability while supporting the smooth onboarding of a new CEO to lead the Company forward in its next phase of growth.' About Organigram Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor of cannabis and manufacturer of cannabis-derived goods in Canada. Through its recent acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets. Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, Collective Project, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). Forward-Looking Information This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as 'plans', 'expects', 'estimates', 'intends', 'anticipates', 'believes' or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include consumer demand and preferences, future prospects and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see and filed or furnished to the Securities and Exchange Commission on EDGAR (see Examples of forward-looking statements in this news release include, among others, statements regarding the Board's intended CEO selection process, Organigram's strategic direction and Ms. Goldenberg's planned focus until her retirement date. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release is made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
